User menu

New targets in idiopathic pulmonary fibrosis: from inflammation and immunity to remodeling and repair

Bibliographic reference Froidure, Antoine ; et. al. New targets in idiopathic pulmonary fibrosis: from inflammation and immunity to remodeling and repair. In: Expert Opinion on Orphan Drugs, Vol. 2016, no.4, p. 511-520 (12 avril 2016)
Permanent URL http://hdl.handle.net/2078.1/182979
  1. King Talmadge E, Pardo Annie, Selman Moisés, Idiopathic pulmonary fibrosis, 10.1016/s0140-6736(11)60052-4
  2. Travis William D., Costabel Ulrich, Hansell David M., King Talmadge E., Lynch David A., Nicholson Andrew G., Ryerson Christopher J., Ryu Jay H., Selman Moisés, Wells Athol U., Behr Jurgen, Bouros Demosthenes, Brown Kevin K., Colby Thomas V., Collard Harold R., Cordeiro Carlos Robalo, Cottin Vincent, Crestani Bruno, Drent Marjolein, Dudden Rosalind F., Egan Jim, Flaherty Kevin, Hogaboam Cory, Inoue Yoshikazu, Johkoh Takeshi, Kim Dong Soon, Kitaichi Masanori, Loyd James, Martinez Fernando J., Myers Jeffrey, Protzko Shandra, Raghu Ganesh, Richeldi Luca, Sverzellati Nicola, Swigris Jeffrey, Valeyre Dominique, An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias, 10.1164/rccm.201308-1483st
  3. Souza Carolina Althoff, Müller Nestor L., Flint Julia, Wright Joanne L., Churg Andrew, Idiopathic Pulmonary Fibrosis: Spectrum of High-Resolution CT Findings, 10.2214/ajr.04.1599
  4. De Cremoux Hubert, Bernaudin Jean-François, Laurent Philippe, Brochard Patrick, Bignon Jean, Interactions between Cigarette Smoking and the Natural History of Idiopathic Pulmonary Fibrosis, 10.1378/chest.98.1.71
  5. Baumgartner K B, Samet J M, Stidley C A, Colby T V, Waldron J A, Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis., 10.1164/ajrccm.155.1.9001319
  6. Raghu Ganesh, Collard Harold R., Egan Jim J., Martinez Fernando J., Behr Juergen, Brown Kevin K., Colby Thomas V., Cordier Jean-François, Flaherty Kevin R., Lasky Joseph A., Lynch David A., Ryu Jay H., Swigris Jeffrey J., Wells Athol U., Ancochea Julio, Bouros Demosthenes, Carvalho Carlos, Costabel Ulrich, Ebina Masahito, Hansell David M., Johkoh Takeshi, Kim Dong Soon, King Talmadge E., Kondoh Yasuhiro, Myers Jeffrey, Müller Nestor L., Nicholson Andrew G., Richeldi Luca, Selman Moisés, Dudden Rosalind F., Griss Barbara S., Protzko Shandra L., Schünemann Holger J., An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management, 10.1164/rccm.2009-040gl
  7. Lee Sang Hoon, Kim Dong Soon, Kim Young Whan, Chung Man Pyo, Uh Soo Taek, Park Choon Sik, Jeong Sung Hwan, Park Yong Bum, Lee Hong Lyeol, Song Jeong Sup, Shin Jong Wook, Yoo Nam Soo, Lee Eun Joo, Lee Jin Hwa, Jegal Yangin, Lee Hyun Kyung, Park Moo Suk, Association Between Occupational Dust Exposure and Prognosis of Idiopathic Pulmonary Fibrosis, 10.1378/chest.14-0994
  8. Raghu G., High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis, 10.1183/09031936.06.00037005
  9. STEWART JAMES P., EGAN JIM J., ROSS ALAN J., KELLY BRIAN G., LOK SHE S., HASLETON PHILIP S., WOODCOCK ASHLEY A., The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis, 10.1164/ajrccm.159.4.9807077
  10. Lasithiotaki Ismini, Antoniou Katerina M., Vlahava Virginia-Maria, Karagiannis Konstantinos, Spandidos Demetrios A., Siafakas Nikolaos M., Sourvinos George, Detection of Herpes Simplex Virus Type-1 in Patients with Fibrotic Lung Diseases, 10.1371/journal.pone.0027800
  11. Sgalla G, Respirology (2016)
  12. Santangelo Simona, Scarlata Simone, Zito Anna, Chiurco Domenica, Pedone Claudio, Incalzi Raffaele Antonelli, Genetic background of idiopathic pulmonary fibrosis, 10.1586/erm.13.22
  13. Kannengiesser Caroline, Borie Raphael, Ménard Christelle, Réocreux Marion, Nitschké Patrick, Gazal Steven, Mal Hervé, Taillé Camille, Cadranel Jacques, Nunes Hilario, Valeyre Dominique, Cordier Jean François, Callebaut Isabelle, Boileau Catherine, Cottin Vincent, Grandchamp Bernard, Revy Patrick, Crestani Bruno, HeterozygousRTEL1mutations are associated with familial pulmonary fibrosis, 10.1183/09031936.00040115
  14. Stuart Bridget D, Choi Jungmin, Zaidi Samir, Xing Chao, Holohan Brody, Chen Rui, Choi Mihwa, Dharwadkar Pooja, Torres Fernando, Girod Carlos E, Weissler Jonathan, Fitzgerald John, Kershaw Corey, Klesney-Tait Julia, Mageto Yolanda, Shay Jerry W, Ji Weizhen, Bilguvar Kaya, Mane Shrikant, Lifton Richard P, Garcia Christine Kim, Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening, 10.1038/ng.3278
  15. Nathan Steven D., Shlobin Oksana A., Weir Nargues, Ahmad Shahzad, Kaldjob Julienne M., Battle Edwinia, Sheridan Michael J., du Bois Roland M., Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium, 10.1378/chest.10-2572
  16. Selman Moisés, Carrillo Guillermo, Estrada Andrea, Mejia Mayra, Becerril Carina, Cisneros José, Gaxiola Miguel, Pérez-Padilla Rogelio, Navarro Carmen, Richards Thomas, Dauber James, King Talmadge E., Pardo Annie, Kaminski Naftali, Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern, 10.1371/journal.pone.0000482
  17. Maher TM, Adv Ther (2015)
  18. Nadrous Hassan F., Pellikka Patricia A., Krowka Michael J., Swanson Karen L., Chaowalit Nithima, Decker Paul A., Ryu Jay H., Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis, 10.1378/chest.128.4.2393
  19. George Timothy J., Lung Transplant in Idiopathic Pulmonary Fibrosis, 10.1001/archsurg.2011.239
  20. Demedts Maurits, Behr Juergen, Buhl Roland, Costabel Ulrich, Dekhuijzen Richard, Jansen Henk M., MacNee William, Thomeer Michiel, Wallaert Benoit, Laurent François, Nicholson Andrew G., Verbeken Eric K., Verschakelen Johny, Flower Christopher D.R., Capron Frédérique, Petruzzelli Stefano, De Vuyst Paul, van den Bosch Jules M.M., Rodriguez-Becerra Eulogio, Corvasce Giuseppina, Lankhorst Ida, Sardina Marco, Montanari Mauro, High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis, 10.1056/nejmoa042976
  21. , Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis, 10.1056/nejmoa1113354
  22. , Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis, 10.1056/nejmoa1401739
  23. King Talmadge E., Bradford Williamson Z., Castro-Bernardini Socorro, Fagan Elizabeth A., Glaspole Ian, Glassberg Marilyn K., Gorina Eduard, Hopkins Peter M., Kardatzke David, Lancaster Lisa, Lederer David J., Nathan Steven D., Pereira Carlos A., Sahn Steven A., Sussman Robert, Swigris Jeffrey J., Noble Paul W., A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis, 10.1056/nejmoa1402582
  24. Noble Paul W, Albera Carlo, Bradford Williamson Z, Costabel Ulrich, Glassberg Marilyn K, Kardatzke David, King Talmadge E, Lancaster Lisa, Sahn Steven A, Szwarcberg Javier, Valeyre Dominique, du Bois Roland M, Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials, 10.1016/s0140-6736(11)60405-4
  25. Aravena Carlos, Labarca Gonzalo, Venegas Carmen, Arenas Alex, Rada Gabriel, Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis, 10.1371/journal.pone.0136160
  26. Noble Paul W., Albera Carlo, Bradford Williamson Z., Costabel Ulrich, du Bois Roland M., Fagan Elizabeth A., Fishman Robert S., Glaspole Ian, Glassberg Marilyn K., Lancaster Lisa, Lederer David J., Leff Jonathan A., Nathan Steven D., Pereira Carlos A., Swigris Jeffrey J., Valeyre Dominique, King Talmadge E., Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials, 10.1183/13993003.00026-2015
  27. Wollin Lutz, Wex Eva, Pautsch Alexander, Schnapp Gisela, Hostettler Katrin E., Stowasser Susanne, Kolb Martin, Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis, 10.1183/09031936.00174914
  28. Richeldi Luca, du Bois Roland M., Raghu Ganesh, Azuma Arata, Brown Kevin K., Costabel Ulrich, Cottin Vincent, Flaherty Kevin R., Hansell David M., Inoue Yoshikazu, Kim Dong Soon, Kolb Martin, Nicholson Andrew G., Noble Paul W., Selman Moisés, Taniguchi Hiroyuki, Brun Michèle, Le Maulf Florence, Girard Mannaïg, Stowasser Susanne, Schlenker-Herceg Rozsa, Disse Bernd, Collard Harold R., Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis, 10.1056/nejmoa1402584
  29. Lee Taehoon, Park Ji Young, Lee Hong Yeul, Cho Young-Jae, Yoon Ho Il, Lee Jae Ho, Jheon Sanghoon, Lee Choon-Taek, Park Jong Sun, Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival, 10.1016/j.rmed.2014.07.020
  30. Nathan N, Hum Mol Genet (2016)
  31. Lenna Stefania, Trojanowska Maria, The role of endoplasmic reticulum stress and the unfolded protein response in fibrosis : , 10.1097/bor.0b013e3283588dbb
  32. Chilosi Marco, Poletti Venerino, Zamò Alberto, Lestani Maurizio, Montagna Licia, Piccoli Paola, Pedron Serena, Bertaso Manuela, Scarpa Aldo, Murer Bruno, Cancellieri Alessandra, Maestro Roberta, Semenzato Gianpietro, Doglioni Claudio, Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis, 10.1016/s0002-9440(10)64282-4
  33. Plantier L., Crestani B., Wert S. E., Dehoux M., Zweytick B., Guenther A., Whitsett J. A., Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis, 10.1136/thx.2010.151555
  34. Seibold Max A., Wise Anastasia L., Speer Marcy C., Steele Mark P., Brown Kevin K., Loyd James E., Fingerlin Tasha E., Zhang Weiming, Gudmundsson Gunnar, Groshong Steve D., Evans Christopher M., Garantziotis Stavros, Adler Kenneth B., Dickey Burton F., du Bois Roland M., Yang Ivana V., Herron Aretha, Kervitsky Dolly, Talbert Janet L., Markin Cheryl, Park Joungjoa, Crews Anne L., Slifer Susan H., Auerbach Scott, Roy Michelle G., Lin Jia, Hennessy Corinne E., Schwarz Marvin I., Schwartz David A., A CommonMUC5BPromoter Polymorphism and Pulmonary Fibrosis, 10.1056/nejmoa1013660
  35. Yang Ivana V, Coldren Christopher D, Leach Sonia M, Seibold Max A, Murphy Elissa, Lin Jia, Rosen Rachel, Neidermyer Amanda J, McKean David F, Groshong Steve D, Cool Carlyne, Cosgrove Gregory P, Lynch David A, Brown Kevin K, Schwarz Marvin I, Fingerlin Tasha E, Schwartz David A, Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis, 10.1136/thoraxjnl-2012-202943
  36. DePianto Daryle J, Chandriani Sanjay, Abbas Alexander R, Jia Guiquan, N'Diaye Elsa N, Caplazi Patrick, Kauder Steven E, Biswas Sabyasachi, Karnik Satyajit K, Ha Connie, Modrusan Zora, Matthay Michael A, Kukreja Jasleen, Collard Harold R, Egen Jackson G, Wolters Paul J, Arron Joseph R, Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis, 10.1136/thoraxjnl-2013-204596
  37. Datta A., Alexander R., Sulikowski M. G., Nicholson A. G., Maher T. M., Scotton C. J., Chambers R. C., Evidence for a Functional Thymic Stromal Lymphopoietin Signaling Axis in Fibrotic Lung Disease, 10.4049/jimmunol.1300588
  38. Froidure A, Allergy (2014)
  39. Chilosi Marco, Poletti Venerino, Murer Bruno, Lestani Maurizio, Cancellieri Alessandra, Montagna Licia, Piccoli Paola, Cangi Giulia, Semenzato Gianpietro, Doglioni Claudio, Abnormal Re-epithelialization and Lung Remodeling in Idiopathic Pulmonary Fibrosis: The Role of ΔN-p63, 10.1097/01.lab.0000032380.82232.67
  40. Honda Takayuki, Uehara Takeshi, Sano Kenji, Heterogeneous proliferation of type II pneumocytes in usual interstitial pneumonia, 10.1080/00313020600922462
  41. Melboucy-Belkhir S., Pradere P., Tadbiri S., Habib S., Bacrot A., Brayer S., Mari B., Besnard V., Mailleux A., Guenther A., Castier Y., Mal H., Crestani B., Plantier L., Forkhead Box F1 represses cell growth and inhibits COL1 and ARPC2 expression in lung fibroblasts in vitro, 10.1152/ajplung.00012.2014
  42. Joannes A, Am J Physiol Lung Cell Mol Physiol (2016)
  43. Fernandez Isis E, Eickelberg Oliver, New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis, 10.1016/s0140-6736(12)61144-1
  44. Cigna Natacha, Farrokhi Moshai Elika, Brayer Stéphanie, Marchal-Somme Joëlle, Wémeau-Stervinou Lidwine, Fabre Aurélie, Mal Hervé, Lesèche Guy, Dehoux Monique, Soler Paul, Crestani Bruno, Mailleux Arnaud A., The Hedgehog System Machinery Controls Transforming Growth Factor-β–Dependent Myofibroblastic Differentiation in Humans, 10.1016/j.ajpath.2012.08.019
  45. Seibold Max A., Smith Russell W., Urbanek Cydney, Groshong Steve D., Cosgrove Gregory P., Brown Kevin K., Schwarz Marvin I., Schwartz David A., Reynolds Susan D., The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium, 10.1371/journal.pone.0058658
  46. Marchal-Sommé Joëlle, Uzunhan Yurdagul, Marchand-Adam Sylvain, Kambouchner Marianne, Valeyre Dominique, Crestani Bruno, Soler Paul, Dendritic Cells Accumulate in Human Fibrotic Interstitial Lung Disease, 10.1164/rccm.200609-1347oc
  47. Ziesche Rolf, Hofbauer Elisabeth, Wittmann Karin, Petkov Ventzislav, Block Lutz-Henning, A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary Fibrosis, 10.1056/nejm199910213411703
  48. Antoniou K. M., Nicholson A. G., Dimadi M., Malagari K., Latsi P., Rapti A., Tzanakis N., Trigidou R., Polychronopoulos V., Bouros D., Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis, 10.1183/09031936.06.00032605
  49. Raghu Ganesh, Brown Kevin K., Bradford Williamson Z., Starko Karen, Noble Paul W., Schwartz David A., King Talmadge E., A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis, 10.1056/nejmoa030511
  50. Molyneaux Phillip L., Cox Michael J., Willis-Owen Saffron A. G., Mallia Patrick, Russell Kirsty E., Russell Anne-Marie, Murphy Elissa, Johnston Sebastian L., Schwartz David A., Wells Athol U., Cookson William O. C., Maher Toby M., Moffatt Miriam F., The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis, 10.1164/rccm.201403-0541oc
  51. Han MeiLan K, Zhou Yueren, Murray Susan, Tayob Nabihah, Noth Imre, Lama Vibha N, Moore Bethany B, White Eric S, Flaherty Kevin R, Huffnagle Gary B, Martinez Fernando J, Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study, 10.1016/s2213-2600(14)70069-4
  52. Habiel David M., Hogaboam Cory, Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis, 10.3389/fphar.2014.00002
  53. Iyer SN, J Pharmacol Exp Ther, 291, 367 (1999)
  54. Lin Xianchai, Yu Minbin, Wu Kaili, Yuan Hongzhi, Zhong Hua, Effects of Pirfenidone on Proliferation, Migration, and Collagen Contraction of Human Tenon’s Fibroblasts In Vitro, 10.1167/iovs.08-2815
  55. Hisatomi Keiko, Mukae Hiroshi, Sakamoto Noriho, Ishimatsu Yuji, Kakugawa Tomoyuki, Hara Shintaro, Fujita Hanako, Nakamichi Seiko, Oku Hisashi, Urata Yoshishige, Kubota Hiroshi, Nagata Kazuhiro, Kohno Shigeru, Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells, 10.1186/1471-2466-12-24
  56. Nakazato Hitoshi, Oku Hisashi, Yamane Shoji, Tsuruta Yuji, Suzuki Ryuji, A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-α at the translational level, 10.1016/s0014-2999(02)01758-2
  57. Giri SN, J Environ Pathol Toxicol Oncol, 18, 169 (1999)
  58. Yamagami Kiyoshi, Oka Toru, Wang Qi, Ishizu Takamaru, Lee Jong-Kook, Miwa Keiko, Akazawa Hiroshi, Naito Atsuhiko T., Sakata Yasushi, Komuro Issei, Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts, 10.1152/ajpheart.00137.2015
  59. Rangarajan Sunad, Kurundkar Ashish, Kurundkar Deepali, Bernard Karen, Sanders Yan Y., Ding Qiang, Antony Veena B., Zhang Jianhua, Zmijewski Jaroslaw, Thannickal Victor J., Novel Mechanisms for the Antifibrotic Action of Nintedanib, 10.1165/rcmb.2014-0445oc
  60. Raghu G, Eur Respir J (2015)
  61. Chien J. W., Richards T. J., Gibson K. F., Zhang Y., Lindell K. O., Shao L., Lyman S. K., Adamkewicz J. I., Smith V., Kaminski N., O'Riordan T., Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression, 10.1183/09031936.00141013
  62. Yoshida Koichiro, Kuwano Kazuyoshi, Hagimoto Naoki, Watanabe Kentaro, Matsuba Tokuji, Fujita Masaki, Inoshima Ichiro, Hara Nobuyuki, MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis, 10.1002/path.1208
  63. Shulgina Ludmila, Cahn Anthony P, Chilvers Edwin R, Parfrey Helen, Clark Allan B, Wilson Edward C F, Twentyman Orion P, Davison Anthony G, Curtin John J, Crawford Michael B, Wilson Andrew M, Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial, 10.1136/thoraxjnl-2012-202403
  64. Wuyts Wim A., Agostini Carlo, Antoniou Katerina M., Bouros Demosthenes, Chambers Rachel C., Cottin Vincent, Egan Jim J., Lambrecht Bart N., Lories Rik, Parfrey Helen, Prasse Antje, Robalo-Cordeiro Carlos, Verbeken Eric, Verschakelen Johny A., Wells Athol U., Verleden Geert M., The pathogenesis of pulmonary fibrosis: a moving target, 10.1183/09031936.00073012
  65. Kreuter M, Respiration (2016)
  66. Lee Joyce S., Ryu Jay H., Elicker Brett M., Lydell Carmen P., Jones Kirk D., Wolters Paul J., King Talmadge E., Collard Harold R., Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis, 10.1164/rccm.201101-0138oc
  67. Lee Joyce S, Collard Harold R, Anstrom Kevin J, Martinez Fernando J, Noth Imre, Roberts Rhonda S, Yow Eric, Raghu Ganesh, Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials, 10.1016/s2213-2600(13)70105-x
  68. Tashiro Jun, Elliot Sharon J., Gerth David J., Xia Xiaomei, Pereira-Simon Simone, Choi Rhea, Catanuto Paola, Shahzeidi Shahriar, Toonkel Rebecca L., Shah Rahil H., El Salem Fadi, Glassberg Marilyn K., Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis, 10.1016/j.trsl.2015.09.004
  69. Pilling D., Roife D., Wang M., Ronkainen S. D., Crawford J. R., Travis E. L., Gomer R. H., Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P, 10.4049/jimmunol.179.6.4035
  70. van den Blink B, Eur Respir J (2016)
  71. Funke Manuela, Zhao Zhenwen, Xu Yan, Chun Jerold, Tager Andrew M., The Lysophosphatidic Acid Receptor LPA1Promotes Epithelial Cell Apoptosis after Lung Injury, 10.1165/rcmb.2010-0155oc
  72. Saini Gauri, Porte Joanne, Weinreb Paul H., Violette Shelia M., Wallace William A., McKeever Tricia M., Jenkins Gisli, αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease, 10.1183/09031936.00210414
  73. Moshai Elika Farrokhi, Wémeau-Stervinou Lidwine, Cigna Natacha, Brayer Stephanie, Sommé Joëlle Marchal, Crestani Bruno, Mailleux Arnaud A., Targeting the Hedgehog–Glioma-Associated Oncogene Homolog Pathway Inhibits Bleomycin-Induced Lung Fibrosis in Mice, 10.1165/rcmb.2013-0154oc
  74. Murray Lynne A., Zhang Huilan, Oak Sameer R., Coelho Ana Lucia, Herath Athula, Flaherty Kevin R., Lee Joyce, Bell Matt, Knight Darryl A., Martinez Fernando J., Sleeman Matthew A., Herzog Erica L., Hogaboam Cory M., Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model, 10.1165/rcmb.2013-0342oc
  75. Yamashita Cory M., Dolgonos Lior, Zemans Rachel L., Young Scott K., Robertson Jennifer, Briones Natalie, Suzuki Tomoko, Campbell Megan N., Gauldie Jack, Radisky Derek C., Riches David W.H., Yu Guoying, Kaminski Naftali, McCulloch Christopher A.G., Downey Gregory P., Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis, 10.1016/j.ajpath.2011.06.041
  76. Craig Vanessa J., Zhang Li, Hagood James S., Owen Caroline A., Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis, 10.1165/rcmb.2015-0020tr
  77. Staab-Weijnitz Claudia A., Fernandez Isis E., Knüppel Larissa, Maul Julia, Heinzelmann Katharina, Juan-Guardela Brenda M., Hennen Elisabeth, Preissler Gerhard, Winter Hauke, Neurohr Claus, Hatz Rudolf, Lindner Michael, Behr Jürgen, Kaminski Naftali, Eickelberg Oliver, FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis, 10.1164/rccm.201412-2233oc
  78. Huang Long Shuang, Mathew Biji, Li Haiquan, Zhao Yutong, Ma Shwu-Fan, Noth Imre, Reddy Sekhar P., Harijith Anantha, Usatyuk Peter V., Berdyshev Evgeny V., Kaminski Naftali, Zhou Tong, Zhang Wei, Zhang Yanmin, Rehman Jalees, Kotha Sainath R., Gurney Travis O., Parinandi Narasimham L., Lussier Yves A., Garcia Joe G. N., Natarajan Viswanathan, The Mitochondrial Cardiolipin Remodeling Enzyme Lysocardiolipin Acyltransferase Is a Novel Target in Pulmonary Fibrosis, 10.1164/rccm.201310-1917oc
  79. Bardou Olivier, Menou Awen, François Charlène, Duitman Jan Willem, von der Thüsen Jan H., Borie Raphaël, Sales Katiuchia Uzzun, Mutze Kathrin, Castier Yves, Sage Edouard, Liu Ligong, Bugge Thomas H., Fairlie David P., Königshoff Mélanie, Crestani Bruno, Borensztajn Keren S., Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis, 10.1164/rccm.201502-0299oc
  80. Konigshoff M, J Clin Invest, 119, 772 (2009)
  81. Kim Tae Hyung, Kim Sang-Heon, Seo Ji-Young, Chung Hana, Kwak Hyun Jung, Lee Sang-Kyung, Yoon Ho Joo, Shin Dong Ho, Park Sung Soo, Sohn Jang Won, Blockade of the Wnt/β-Catenin Pathway Attenuates Bleomycin-Induced Pulmonary Fibrosis, 10.1620/tjem.223.45
  82. Rajasekaran Subbiah, Rajaguru P., Sudhakar Gandhi P. S., MicroRNAs as potential targets for progressive pulmonary fibrosis, 10.3389/fphar.2015.00254
  83. Zhou Yong, Huang Xiangwei, Hecker Louise, Kurundkar Deepali, Kurundkar Ashish, Liu Hui, Jin Tong-Huan, Desai Leena, Bernard Karen, Thannickal Victor J., Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis, 10.1172/jci66700
  84. Liu Fei, Lagares David, Choi Kyoung Moo, Stopfer Lauren, Marinković Aleksandar, Vrbanac Vladimir, Probst Clemens K., Hiemer Samantha E., Sisson Thomas H., Horowitz Jeffrey C., Rosas Ivan O., Fredenburgh Laura E., Feghali-Bostwick Carol, Varelas Xaralabos, Tager Andrew M., Tschumperlin Daniel J., Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis, 10.1152/ajplung.00300.2014
  85. José Ricardo J, Williams Andrew E, Chambers Rachel C, Proteinase-activated receptors in fibroproliferative lung disease, 10.1136/thoraxjnl-2013-204367
  86. Lin Cong, von der Thüsen Jan, Daalhuisen Joost, ten Brink Marieke, Crestani Bruno, van der Poll Tom, Borensztajn Keren, Spek C. Arnold, Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis, 10.1111/jcmm.12520
  87. Wettstein G., Bellaye P.-S., Kolb M., Hammann A., Crestani B., Soler P., Marchal-Somme J., Hazoume A., Gauldie J., Gunther A., Micheau O., Gleave M., Camus P., Garrido C., Bonniaud P., Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation, 10.1096/fj.12-220053
  88. Guillamat-Prats Raquel, Gay-Jordi Gemma, Xaubet Antoni, Peinado Victor I., Serrano-Mollar Anna, Alveolar Type II cell transplantation restores pulmonary surfactant protein levels in lung fibrosis, 10.1016/j.healun.2014.03.008
  89. Serrano-Mollar Anna, Nacher Maria, Gay-Jordi Gemma, Closa Daniel, Xaubet Antoni, Bulbena Oriol, Intratracheal Transplantation of Alveolar Type II Cells Reverses Bleomycin-induced Lung Fibrosis, 10.1164/rccm.200610-1491oc
  90. Degryse Amber L., Lawson William E., Progress Toward Improving Animal Models for Idiopathic Pulmonary Fibrosis, 10.1097/maj.0b013e31821aa000
  91. Degryse A. L., Tanjore H., Xu X. C., Polosukhin V. V., Jones B. R., McMahon F. B., Gleaves L. A., Blackwell T. S., Lawson W. E., Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis, 10.1152/ajplung.00026.2010
  92. Liang Minrui, Lv Jiaoyan, Zou Linlin, Yang Wei, Xiong Yingluo, Chen Xiangjun, Guan Ming, He Rui, Zou Hejian, A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis, 10.1038/labinvest.2014.145
  93. Parra Edwin Roger, Boufelli Gabriela, Bertanha Fernanda, Samorano Luciana de Paula, Aguiar Junior Armando Costa, Costa Fernanda Magalhães Arantes, Capelozzi Vera Luiza, Barbas-Filho João Valente, Temporal evolution of epithelial, vascular and interstitial lung injury in an experimental model of idiopathic pulmonary fibrosis induced by butyl-hydroxytoluene : UIP in experimental model, 10.1111/j.1365-2613.2008.00600.x
  94. Parra E.R., Pincelli M.S., Teodoro W.R., Velosa A.P.P., Martins V., Rangel M.P., Barbas-Filho J.V., Capelozzi V.L., Modeling pulmonary fibrosis by abnormal expression of telomerase/apoptosis/collagen V in experimental usual interstitial pneumonia, 10.1590/1414-431x20143522
  95. Decologne N., Kolb M., Margetts P. J., Menetrier F., Artur Y., Garrido C., Gauldie J., Camus P., Bonniaud P., TGF- 1 Induces Progressive Pleural Scarring and Subpleural Fibrosis, 10.4049/jimmunol.179.9.6043
  96. Povedano Juan M., Martinez Paula, Flores Juana M., Mulero Francisca, Blasco Maria A., Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction, 10.1016/j.celrep.2015.06.028
  97. Jenkins Gisli, Blanchard Andrew, Borok Zea, Bradding Peter, Ehrhardt Carsten, Fisher Andrew, Hirani Nik, Johnson Simon, Königshoff Melanie, Maher Toby M, Millar Ann, Parfrey Helen, Scotton Chris, Tetley Terry, Thickett David, Wolters Paul, In search of the fibrotic epithelial cell: opportunities for a collaborative network, 10.1136/thoraxjnl-2011-200195
  98. Costabel Ulrich, Inoue Yoshikazu, Richeldi Luca, Collard Harold R., Tschoepe Inga, Stowasser Susanne, Azuma Arata, Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS, 10.1164/rccm.201503-0562oc
  99. Naik P. K., Bozyk P. D., Bentley J. K., Popova A. P., Birch C. M., Wilke C. A., Fry C. D., White E. S., Sisson T. H., Tayob N., Carnemolla B., Orecchia P., Flaherty K. R., Hershenson M. B., Murray S., Martinez F. J., Moore B. B., , Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis, 10.1152/ajplung.00139.2012
  100. Tominaga J, Eur J Radio L (2015)
  101. Behr Jürgen, Kreuter Michael, Hoeper Marius M., Wirtz Hubert, Klotsche Jens, Koschel Dirk, Andreas Stefan, Claussen Martin, Grohé Christian, Wilkens Henrike, Randerath Winfried, Skowasch Dirk, Meyer F. Joachim, Kirschner Joachim, Gläser Sven, Herth Felix J.F., Welte Tobias, Huber Rudolf Maria, Neurohr Claus, Schwaiblmair Martin, Kohlhäufl Martin, Höffken Gert, Held Matthias, Koch Andrea, Bahmer Thomas, Pittrow David, Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry, 10.1183/09031936.00217614
  102. Xaubet Antoni, Serrano-Mollar Anna, Ancochea Julio, Pirfenidone for the treatment of idiopathic pulmonary fibrosis, 10.1517/14656566.2014.867328
  103. Wuyts Wim A, Antoniou Katerina M, Borensztajn Keren, Costabel Ulrich, Cottin Vincent, Crestani Bruno, Grutters Jan C, Maher Toby M, Poletti Venerino, Richeldi Luca, Vancheri Carlo, Wells Athol U, Combination therapy: the future of management for idiopathic pulmonary fibrosis?, 10.1016/s2213-2600(14)70232-2
  104. Loveman Emma, Copley Vicky R, Colquitt Jill, Scott David A, Clegg Andy, Jones Jeremy, O’Reilly Katherine MA, Singh Sally, Bausewein Claudia, Wells Athol, The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation, 10.3310/hta19200
  105. Loveman Emma, Copley Vicky R, Colquitt Jill L, Scott David A, Clegg Andy J, Jones Jeremy, O’Reilly Katherine MA, Singh Sally, Bausewein Claudia, Wells Athol, The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation, 10.1186/2050-6511-15-63
  106. Bonella Francesco, Wijsenbeek Marlies, Molina-Molina Maria, Duck Annette, Mele Rosalba, Geissler Klaus, Wuyts Wim, European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers, 10.1183/13993003.01204-2015
  107. Crestani Bruno, European IPF Patient Charter: an SOS to the world, 10.1183/13993003.01902-2015